Certest Biotec, S.L. is a biotechnology company founded in 2002. The company specializes in providing products and solutions for Raw Materials, Diagnostics, and Pharma. With a strong focus on customer orientation, Certest Biotec operates under four divisions, namely Raw Materials, Immunodiagnostics (Rapid Tests, Turbidimetry, and CLIA), Molecular Biology under the VIASURE brand, and Pharma. Certest Raw Materials offers high-quality solutions for developing and manufacturing IVD assays, including expertise in protein expression & purification, monoclonal antibodies development & manufacturing, and primers & probes manufacturing. Certest Immunodiagnostic is dedicated to offering a comprehensive portfolio of diagnostic reagents for detecting infectious diseases and different markers, tailored to various needs of formats, types of use, throughput, precision, and time from sample to result. VIASURE provides a reliable molecular diagnostic solution, covering a wide range portfolio of products and enabling laboratories to inform clinical decisions effectively. Certest Pharma aims to contribute its technology to obtain better therapeutic products based on RNA, focusing on three main areas: RNAs, Delivery, and Vaccines. The company's team, comprising over 300 employees, offers development and manufacturing services for the production of custom materials, showcasing Certest Biotec's comprehensive capabilities.
There is no investment information
No recent news or press coverage available for Certest Biotec, S.L..